Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Mayuree, Fuangthong"'
Autor:
Kamonwan Phatinuwat, Sopapan Atichartpongkul, Watthanachai Jumpathong, Skorn Mongkolsuk, Mayuree Fuangthong
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Ribosomal RNA (rRNA) modifications are involved in multiple biological processes. KsgA is a 16S rRNA adenine dimethyltransferase that methylates at the adenines 1518 and 1519 (A1518/1519) positions, which are located near the ribosome decodi
Externí odkaz:
https://doaj.org/article/3186c65f72604dc8abb7c133c16dfcf5
Autor:
Wachira Kajornsrichon, Jittiporn Chaisaingmongkol, Yotsawat Pomyen, Phanthakarn Tit-oon, Xin Wei Wang, Mathuros Ruchirawat, Mayuree Fuangthong
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Intrahepatic cholangiocarcinoma (iCCA) presents a challenging diagnosis due to its nonspecific early clinical manifestations, often resulting in late-stage detection and high mortality. Diagnosing iCCA is further complicated by its limited a
Externí odkaz:
https://doaj.org/article/30973bf173744f25bcbbf96b80e6757d
Autor:
Phanthakarn Tit-oon, Arisa Wonglangka, Klaichan Boonkanta, Mathuros Ruchirawat, Mayuree Fuangthong, Ram Sasisekharan, Amnart Khongmanee
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Programmed cell death protein 1 (PD-1) is a key receptor in the immune checkpoint pathway and has emerged to be a promising target for cancer therapy. PD-1 consists of an intracellular domain followed by a transmembrane domain that is connec
Externí odkaz:
https://doaj.org/article/e95a1c2c70154dffa1b54540decfe6a9
Autor:
Sitthiphol Puarattana-aroonkorn, Kannan Tharakaraman, Disapan Suriyawipada, Mathuros Ruchirawat, Mayuree Fuangthong, Ram Sasisekharan, Charlermchai Artpradit
Publikováno v:
Vaccines, Vol 12, Iss 6, p 561 (2024)
At times of pandemics, such as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the situation demands rapid development and production timelines of safe and effective vaccines for delivering life-saving medications quickly
Externí odkaz:
https://doaj.org/article/2c1d53313fdb4ede986ea96ffc42f22d
Autor:
Karnpob Kanhasut, Kannan Tharakaraman, Mathuros Ruchirawat, Jutamaad Satayavivad, Mayuree Fuangthong, Ram Sasisekharan
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Burosumab, an FGF23 targeting monoclonal antibody, was approved by the FDA in 2018 for use in children and adults with X-linked hypophosphatemia (or XLH). While several clinical studies have demonstrated the long-term safety and efficacy of
Externí odkaz:
https://doaj.org/article/e3aea1ca9ff2463c96f0dc072a8e04af
Autor:
Thanyaporn Srimahaeak, Narumon Thongdee, Jurairat Chittrakanwong, Sopapan Atichartpongkul, Juthamas Jaroensuk, Kamonwan Phatinuwat, Narumon Phaonakrop, Janthima Jaresitthikunchai, Sittiruk Roytrakul, Skorn Mongkolsuk, Mayuree Fuangthong
Publikováno v:
Frontiers in Microbiology, Vol 13 (2023)
Pseudomonas aeruginosa gidA, which encodes a putative tRNA-modifying enzyme, is associated with a variety of virulence phenotypes. Here, we demonstrated that P. aeruginosa gidA is responsible for the modifications of uridine in tRNAs in vivo. Loss of
Externí odkaz:
https://doaj.org/article/52567aab93074bc0bb7d508bb2f506e3
Autor:
Yordkhwan W. Iwasaki, Kannan Tharakaraman, Vidya Subramanian, Amnart Khongmanee, Andrew Hatas, Eduardo Fleischer, Troy T. Rurak, Patchara Ngok-ngam, Phanthakarn Tit-oon, Mathuros Ruchirawat, Jutamaad Satayavivad, Mayuree Fuangthong, Ram Sasisekharan
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Bispecific antibodies (BsAbs) form an exciting class of bio-therapeutics owing to their multispecificity. Although numerous formats have been developed, generation of hetero-tetrameric IgG1-like BsAbs having acceptable safety and pharmacokinetics pro
Externí odkaz:
https://doaj.org/article/0b05f98023ee4509875b0b2c461a97c0
Autor:
Thanutsorn Susantad, Mayuree Fuangthong, Kannan Tharakaraman, Phanthakarn Tit-oon, Mathuros Ruchirawat, Ram Sasisekharan
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Recombinant human erythropoietin (rHuEPO) is a biopharmaceutical drug given to patients who have a low hemoglobin related to chronic kidney disease, cancer or anemia. However, some patients repeatedly receiving rHuEPO develop anti-rHuEPO neu
Externí odkaz:
https://doaj.org/article/18ae4af54d95460894f2257d68c11d8a
Autor:
Juthamas Jaroensuk, Chalermroj Sutthaphirom, Jittima Phonbuppha, Wachirawit Chinantuya, Chatchai Kesornpun, Nattanon Akeratchatapan, Narongyot Kittipanukul, Kamonwan Phatinuwat, Sopapan Atichartpongkul, Mayuree Fuangthong, Thunyarat Pongtharangkul, Frank Hollmann, Pimchai Chaiyen
Cofactor imbalance obstructs the productivities of metabolically engineered cells. Herein, we employed a minimally perturbing system, xylose reductase and lactose (XR/lactose), to increase levels of a pool of sugar-phosphates which are connected to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de01366b00cf709e91745e68c692b68e
https://doi.org/10.1101/2023.01.08.523081
https://doi.org/10.1101/2023.01.08.523081
Autor:
Phanthakarn Tit-oon, Arisa Wonglangka, Klaichan Boonkanta, Mathuros Ruchirawat, Mayuree Fuangthong, Amnart Khongmanee, Ram Sasisekharan
Programmed cell death protein 1 (PD-1) is a key receptor in the immune checkpoint pathway and has emerged to be a promising target for cancer therapy. PD-1 consists of an intracellular domain followed by a transmembrane domain that is connected to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4fdd7f95f07b501da489364f7c19249
https://doi.org/10.21203/rs.3.rs-2260190/v1
https://doi.org/10.21203/rs.3.rs-2260190/v1